Skip to main content

Rates of Severe Multiple Drug Intolerance Syndrome Up in Fibromyalgia, IBS

Medically reviewed by Carmen Pope, BPharm. Last updated on May 23, 2024.

By Elana Gotkine HealthDay Reporter

THURSDAY, May 23, 2024 -- Patients with fibromyalgia and irritable bowel syndrome (IBS) have increased rates of severe multiple drug intolerance syndrome (MDIS), according to a study published in the May issue of the Journal of Allergy and Clinical Immunology: In Practice.

Alicia A. Alvarez, M.D., from Sarasota Memorial Hospital in Florida, and colleagues conducted a retrospective chart review to examine the prevalence of MDIS in patients diagnosed with fibromyalgia or IBS. Patients who had been seen at a large academic center were identified and matched to controls seen within the same timeframe by exact birthdate and sex.

The researchers found that compared with controls, patients with fibromyalgia and IBS were 12 and three times more likely to have severe MDIS, respectively. In both groups, severe MDIS was associated with polypharmacy. Across all participants, opiates were the most frequently reported drug intolerance. Patients with IBS more often reported gastrointestinal symptoms as adverse reactions, while those with fibromyalgia did not report pain or behavioral changes as adverse reactions more often.

"Further evaluation is needed to understand which patients with fibromyalgia or IBS are at risk of developing MDIS and whether this can be prevented, possibly by reducing polypharmacy," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted May 2024

Read this next

Healthy Lifestyle Cuts Risk for Irritable Bowel Syndrome

WEDNESDAY, Feb. 21, 2024 -- Adhering to a higher number of healthy lifestyle behaviors is significantly associated with a lower incidence of irritable bowel syndrome (IBS)...

American College of Rheumatology, Nov. 10-15

The annual meeting of the American College of Rheumatology was held this year from Nov. 10 to 15 in San Diego, and attendees included rheumatology specialists, physicians...

ACR: App Helps Manage Fibromyalgia Through Acceptance and Commitment Therapy

TUESDAY, Nov. 21, 2023 -- A smartphone-based acceptance and commitment therapy (ACT) app may help patients manage fibromyalgia (FM), according to a study presented at the annual...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.